New Study Reveals Genetic Mutation Significantly Increases Lung Cancer Risk
A recent study highlighted the link between a rare genetic mutation and a dramatically higher chance of developing lung cancer, even for those who have never smoked. The mutation, known as EGFR T790M, is reported to elevate the risk by 25 times compared to individuals without it.
The analysis shows that among non-smokers, those with this genetic variant faced approximately 62 times the likelihood of lung cancer compared to their non-mutated counterparts. This important research was led by experts from the Dana-Farber Cancer Institute and the 23andMe Research Institute, and findings have been published in the journal “Science.”
Interestingly, the study found no increased risk of other cancers when examining data from over 3.3 million people.
Dr. Jaclyn LoPiccolo, a researcher involved in the study, noted, “Currently, lung cancer screenings are largely based on smoking habits. Our findings suggest that in the future, we may also consider inherited genetic risks for such screenings.” If further research proves beneficial, genetic testing could help identify individuals carrying the mutation, allowing for personalized screening strategies that could detect lung cancer at earlier, more treatable stages.
The research also pinpointed that many individuals with the mutation traced their ancestry back to British and Irish settlers in Southern Appalachia around 200 to 225 years ago. The mutation itself is rare across the country, affecting approximately one in 15,000 to 16,000 people. However, its frequency increases in certain regions, with estimates suggesting that one in 2,000 people in Southern Appalachia may be carriers.
The study highlights how ancestral lines can influence health risks generations later. “It’s remarkable how one mutation can have such a powerful impact,” remarked Alexander Gusev, a geneticist at Dana-Farber. He explained that the combination of this mutation and smoking significantly raises lung cancer risk, emphasizing that non-smokers should still be vigilant about their genetic background.
Researchers advise anyone with a substantial family history of lung cancer, multiple lung nodules, or family connections to certain southeastern areas in the U.S. to consult with a genetic counselor regarding potential genetic testing or early lung cancer screenings.
While this study shows a strong correlation between the mutation and lung cancer risk, the researchers also acknowledged some limitations. The rarity of the mutation means that precise risk assessments remain uncertain, and the study population may not represent everyone due to its reliance on 23andMe participants. Despite these limitations, the findings underscore the importance of understanding genetic factors in cancer risk.
This study was partially funded by the National Institutes of Health and the American Cancer Society, aiming to enhance awareness and screening practices for lung cancer.
